IceCure Medical Ltd
ICCM
$1.13
-$0.025-2.17%
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -30.28% | 7.90% | 33.65% | -48.42% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -30.28% | 7.90% | 33.65% | -48.42% | |
| Cost of Revenue | -33.24% | -4.37% | 43.51% | -25.21% | |
| Gross Profit | -26.71% | 22.12% | 23.43% | -113.86% | |
| SG&A Expenses | 54.55% | -10.80% | -2.55% | -6.40% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 15.63% | -15.52% | -4.13% | -6.02% | |
| Operating Income | -32.50% | 20.90% | 13.15% | -0.54% | |
| Income Before Tax | -49.55% | 20.78% | 24.22% | 1.43% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -49.55% | 20.78% | 24.22% | 1.43% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -49.55% | 20.78% | 24.22% | 1.43% | |
| EBIT | -32.50% | 20.90% | 13.15% | -0.54% | |
| EBITDA | -33.34% | 21.39% | 13.63% | -0.25% | |
| EPS Basic | -21.95% | 26.17% | 37.58% | 20.42% | |
| Normalized Basic EPS | -21.95% | 26.27% | 37.60% | -- | |
| EPS Diluted | -21.95% | 26.17% | 37.58% | 20.42% | |
| Normalized Diluted EPS | -21.95% | 26.27% | 37.60% | -- | |
| Average Basic Shares Outstanding | 22.62% | 7.33% | 21.45% | 23.89% | |
| Average Diluted Shares Outstanding | 22.62% | 7.33% | 21.45% | 23.89% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
